Madison, MS

Madison, Mississippi 39110

1 studies enrolling now · 3 studies all time

What they study most

Branch Retinal Vein Occlusion (BRVO), Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (NVAMD)

Studies at this site

• A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO — Recruiting now
• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling